financetom
Business
financetom
/
Business
/
Pratt engine supply doubts weigh on Airbus output goal, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pratt engine supply doubts weigh on Airbus output goal, sources say
Mar 11, 2026 3:02 AM

SINGAPORE, Feb 5 (Reuters) - Airbus' main aircraft production target hangs in the balance as the planemaker remains without a supply deal with engine maker Pratt & Whitney, industry sources said.

The companies are bogged down ‌in a dispute over allocations of engines between Airbus production lines and the ​maintenance shops that serve airlines, and have yet to reach ‍a crucial engine supply agreement for both ⁠2026 and 2027.

Airbus ⁠said last month engines were arriving "very, very late" and particularly those from RTX-owned ‌Pratt & Whitney, with which it ​had yet to reach an agreement for this year and next.

On Wednesday, the president of Pratt & Whitney's ⁠commercial engines division, Rick Deurloo, ‍said ​at the Singapore Airshow he was confident an agreement would be reached.

A deal is increasingly vital as the clock ‍ticks towards Airbus earnings on February 19, the sources said on condition of anonymity because the talks are private.

Airbus declined to comment.

A key issue at stake is whether or to what extent the planemaker can stick to a production ​target ‍of 75 narrowbody jets a month in 2027, up from about 60 a month now.

Pratt & Whitney supplies engines ​for about 40% of the benchmark A320neo-family jets being assembled.

Although engines continue to be supplied on a hand-to-mouth basis, uncertainty over the delivery stream makes it challenging to assess the probability needed to underpin any formal target.

The company delivered 19 planes in January, down ​from 25 in the first month last year, industry sources said.

Bloomberg News reported last week that Airbus had yet to settle on a 2026 delivery target ‍due to engine shortages.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Draganfly and Palladyne Complete
Draganfly and Palladyne Complete "Key" Integration Milestone
Mar 23, 2026
09:03 AM EDT, 03/23/2026 (MT Newswires) -- Draganfly ( DPRO ) , a developer of drone solutions and systems, and Palladyne AI Corp. ( PDYN ) , a developer of advanced artificial intelligence and autonomous systems, announced Monday the completion of a key integration milestone. According to a statement the companies have tested Palladyne AI's ( PDYN ) SwarmOS platform...
Alibaba launches latest agentic AI platform with international unit's Accio Work
Alibaba launches latest agentic AI platform with international unit's Accio Work
Mar 23, 2026
SHANGHAI, March 23 (Reuters) - Alibaba ( BABA ) has pushed further into the global race for agentic artificial intelligence, with its international commerce division launching Accio Work, a plug-and-play AI taskforce it says can autonomously run complex business operations for small and medium-sized enterprises. The launch comes amid a boom in China around agentic AI triggered by OpenClaw, which...
Abacus Unveils Unified Brand Following 2025 Merger with Medicus IT
Abacus Unveils Unified Brand Following 2025 Merger with Medicus IT
Mar 23, 2026
Abacus becomes the official name of the combined organization, bringing together the strengths of both companies to advance and safeguard critical technologies in financial services and healthcare. NEW YORK, March 23, 2026 /PRNewswire/ -- Abacus announced today the launch of its refreshed brand identity, marking a major milestone in the integration of Abacus Group LLC and Medicus IT following their July...
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric D
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric D
Mar 23, 2026
TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ( WGRX ) (Wellgistics or the Company) today announced that it has entered into a non-exclusive, non-binding Letter of Intent (LOI) to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization. The proposed all stock transaction, if completed, is intended to enhance Wellgistics' existing revenue-generating...
Copyright 2023-2026 - www.financetom.com All Rights Reserved